Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

This study has been terminated.
Information provided by (Responsible Party):
Akros Pharma Inc. Identifier:
First received: October 14, 2009
Last updated: January 31, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 31, 2013